Targeting hypoxic tumor microenvironment in pancreatic cancer

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment

Background:

• Pancreatic cancer is a leading cause of cancer death due to late diagnosis and aggressive progression.
• Tumor hypoxia is a hallmark of pancreatic cancer, stemming from poor vascularization and dense stroma.
• Hypoxia significantly influences pancreatic cancer's malignant phenotypes, including metabolic reprogramming, stemness, invasion, metastasis, and angiogenesis.

Purpose of the Study:

• To elucidate the molecular mechanisms by which intratumoral hypoxia drives pancreatic cancer progression and therapeutic resistance.
• To review current and emerging hypoxia-based antitumoral strategies for pancreatic cancer treatment.
• To highlight the potential of targeting the hypoxic microenvironment to enhance treatment efficacy and reduce toxicity.

Main Methods:

• Review of existing literature on pancreatic cancer biology and hypoxia.
• Analysis of molecular pathways regulated by hypoxia, including redox homeostasis, autophagy, epigenetics, and hypoxia-inducible factors.
• Examination of preclinical and clinical data on hypoxia-targeting therapies.

Main Results:

• Hypoxia promotes aggressive phenotypes in both cancer and stromal cells within the pancreatic tumor microenvironment.
• Mechanisms include metabolic reprogramming, enhanced cancer stemness, increased invasion and metastasis, and pathological angiogenesis.
• Hypoxia contributes significantly to resistance against conventional therapies like chemotherapy and radiotherapy.

Conclusions:

• Intratumoral hypoxia is a critical driver of pancreatic cancer's lethality and therapeutic resistance.
• Targeting the hypoxic tumor microenvironment presents a promising therapeutic avenue.
• Hypoxia-based strategies hold potential for improving treatment efficacy and minimizing side effects in pancreatic cancer patients.